DRMA

Dermata Therapeutics, Inc. DRMA

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode DRMA ATXI WINT CARM PBM LIPO VRAX ELAB GTBP REVB
6M 216.66 % 118.21 % -92.98 % -89.12 % -78.99 % -86.97 % -50.91 % -68.65 % -75.18 % -60.14 %
YTD 53.96 % -66.22 % -99.76 % -89.09 % -93.13 % -93.24 % -82.36 % -96.28 % -74.26 % -97.17 %
1Y 73.98 % -63.78 % -99.75 % -87.63 % -94.00 % -93.06 % -79.70 % -96.47 % -73.06 % -93.85 %
3Y -94.99 % -99.34 % -100.00 % -99.52 % -99.97 % -99.40 % -93.22 % -99.99 % -97.75 % -99.99 %
5Y -99.83 % -99.99 % -100.00 % -99.81 % -99.97 % -96.26 % -99.79 % -99.99 % -99.70 % -100.00 %
10Y -99.83 % -99.99 % -100.00 % -99.92 % -99.97 % -96.26 % -99.79 % -99.99 % -100.00 % -100.00 %
From the beginning -99.83 % -99.99 % -100.00 % -99.98 % -99.97 % -96.26 % -99.79 % -99.99 % -100.00 % -100.00 %

Dividend

Carisma Therapeutics, Inc.